A Clinical Controlled Trial on the Effect of Physical Activity After Cancer Treatment (PACT)
NCT ID: NCT00717717
Last Updated: 2015-10-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
214 participants
INTERVENTIONAL
2006-11-30
2012-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors
NCT03523195
Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL)
NCT01404520
Rehabilitation Including Social and Physical Activity in Children and Teenagers With Cancer
NCT01772862
Attitudes Toward Physical Activity and Nutrition Intervention During Cancer Treatment
NCT02887196
A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
NCT00853164
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of the study is to investigate the effect of a 12-month rehabilitation program comprising supervised and structured physical exercise training (body conditioning; strength-building; relaxation; massage), patient education and coaching combined with a home-based physical exercise group component and will include a control group. Groups of 12-15 patients will be formed (mixed genders; different oncological and hematological diagnoses) who will train together once weekly during the intervention period. Participation in a training program with peers is seen as a positive motivational factor that stimulates and challenges the patient through physical activity, to use his/her own resources to establish sustainable coping strategies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
No intervention except repeated measurements of physical capacity
No interventions assigned to this group
Intervention
Intervention: One-year rehabilitation program including weekly supervised and group-based physical exercise, home-based physical activity, individual and group-based coaching (narrative therapy), and expert educational talks/lectures
Intervention
One-year rehabilitation program including weekly supervised and group-based physical exercise, home-based physical activity, individual and group-based coaching (narrative therapy), and expert educational talks/lectures
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention
One-year rehabilitation program including weekly supervised and group-based physical exercise, home-based physical activity, individual and group-based coaching (narrative therapy), and expert educational talks/lectures
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Completed cytostatic treatment \<6 months
* Affiliated with either the Oncology or Hematology Clinic at the Copenhagen University Hospital, Copenhagen
* Between the ages of 15-70 years
* No evidence of disease or life expectancy \>2 years.
Exclusion Criteria
* Bone and brain metastases
* Multiple myeloma (in the case of hematological patients)
* Symptomatic cardiac illness, including clinical congestive heart disease, treatment caused arrhythmia or myocardial infarction experienced within the previous three months
* Dementia and/or psychosis
* Patients who cannot read or write Danish.
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Velux Fonden
OTHER
Danish Cancer Society
OTHER
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Julie Midtgaard
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Julie Midtgaard, PhD
Role: PRINCIPAL_INVESTIGATOR
The University Hospitals Centre for Nursing and Care Research (UCSF) / Copenhagen University Hospital (Rigshospitalet)
Mikael Rørth, PhD
Role: STUDY_DIRECTOR
Department of Oncology, Copenhagen University Hospital
Lis Adamsen, Professor
Role: STUDY_DIRECTOR
The University Hospitals Centre for Nursing and Care Research (UCSF) / Copenhagen University Hospital
Related Links
Access external resources that provide additional context or updates about the study.
Official institutional website
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PACT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.